Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-31 12:41 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | FRANKLIN RESOURCES INC BEN | 1,760,056 8.500% | 1,760,056 (New Position) | Filing History |
| 2024-10-30 9:34 pm Purchase | 2024-10-29 | 13G | Adverum Biotechnologies, Inc. ADVM | Stern Augustus | 1,116,628 5.370% | 1,116,628 (New Position) | Filing History |
| 2024-10-23 1:34 pm Purchase | 2024-10-22 | 13G | Adverum Biotechnologies, Inc. ADVM | Principia Wealth Advisory LLC | 1,055,103 5.070% | 1,055,103 (New Position) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM | BlackRock Inc. BLK | 1,490,709 7.200% | 1,490,709 (New Position) | Filing History |
| 2024-07-22 4:24 pm Purchase | 2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | Filing History |
| 2024-05-14 5:06 pm Sale | 2024-03-21 | 13D | Adverum Biotechnologies, Inc. ADVM | Versant Ventures IV LLC | 500,387 2.400% | -2 (-0.00%) | Filing History |
| 2024-04-29 4:10 pm Purchase | 2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 1,141,000 5.500% | 655,575 (+135.05%) | Filing History |
| 2024-02-22 3:47 pm Purchase | 2024-02-06 | 13G | Adverum Biotechnologies, Inc. ADVM | Logos Global Management LP | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |
| 2024-02-15 4:17 pm Purchase | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | TCG Crossover GP II, LLC | 2,076,357 9.900% | 2,076,357 (New Position) | Filing History |
| 2024-02-14 8:26 pm Purchase | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 1,556,421 7.500% | 966,472 (+163.82%) | Filing History |
| 2024-02-14 4:30 pm Purchase | 2024-02-07 | 13G | Adverum Biotechnologies, Inc. ADVM | Vivo Opportunity Fund Holdings, L.P. | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 1,000,000 9.900% | 384,186 (+62.39%) | Filing History |
| 2024-02-13 7:34 pm Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BANK OF AMERICA CORP BAC | 442,590 4.400% | -116,600 (-20.85%) | Filing History |
| 2024-02-12 10:13 am Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | MORGAN STANLEY MS | 515,050 5.100% | -198,456 (-27.81%) | Filing History |
| 2024-02-09 11:41 am Purchase | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 1,041,667 11.000% | 1,041,667 (New Position) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 612,427 6.062% | -164,860 (-21.21%) | Filing History |
| 2024-02-07 11:36 am Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 485,425 2.300% | -244,593 (-33.51%) | Filing History |
| 2023-07-24 4:16 pm Purchase | 2023-07-14 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 589,949 5.900% | 589,949 (New Position) | Filing History |
| 2023-04-20 4:05 pm Purchase | 2023-04-10 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 615,814 6.100% | 615,814 (New Position) | Filing History |
| 2023-02-14 10:20 am Sale | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 0 0.000% | -755,482 (Position Closed) | Filing History |